MMP16
MMP16 (matrix metallopeptidase 16, also known as MT3-MMP) is a membrane-associated endopeptidase of the M10 matrix metallopeptidase group. It degrades extracellular matrix components such as collagen type III and fibronectin, and activates progelatinase A. Browse Assay Genie's current range of MMP16 research reagents below, or read on for the biology behind the target.
MMP16 is an endopeptidase that degrades various components of the extracellular matrix, including collagen type III and fibronectin. It also activates progelatinase A, the proenzyme form of MMP2, by cleavage. UniProt notes a role in the matrix remodelling of blood vessels. A short isoform cleaves fibronectin and collagen type III as well, but at a lower rate. The protein has no effect on type I, II, IV and V collagen; however, upon interaction with CSPG4 it may contribute to the degradation and invasion of type I collagen by melanoma cells.
The MMP16 protein belongs to the peptidase M10A family and sits in the HGNC group of M10 matrix metallopeptidases. It is found at the cell membrane and cell surface, and is also annotated in the secreted extracellular matrix. Like most MMPs, it is made as an inactive proprotein that is activated by cleavage. The human MMP16 gene is orthologous to mouse and rat Mmp16.
Matrix metalloproteinases as a family are involved in the breakdown of extracellular matrix in normal physiological processes such as embryonic development, reproduction and tissue remodelling, as well as in disease processes such as arthritis and metastasis. The gene was once referred to as MT-MMP2 before being renamed MT-MMP3 or MMP16, and has also carried the symbol C8orf57 and the alias DKFZp761D112.
MMP16 degrades collagen type III and fibronectin, making it a useful subject for studies of how matrix components are broken down in tissues.
MMP16 activates progelatinase A (MMP2) by cleavage, linking membrane-associated proteases to gelatinase activation.
UniProt associates MMP16 with matrix remodelling of blood vessels, relevant to research on vessel wall structure and change.
Through interaction with CSPG4, MMP16 may contribute to type I collagen degradation and invasion by melanoma cells.
MMP16 is an endopeptidase that degrades extracellular matrix components such as collagen type III and fibronectin. It activates progelatinase A (MMP2) by cleavage and is involved in matrix remodelling of blood vessels. It has no effect on collagen types I, II, IV and V.
MMP16 is also called MT3-MMP (MT-MMP3) and matrix metalloproteinase-16. Earlier names include MT-MMP2, chromosome 8 open reading frame 57 (C8orf57) and the clone alias DKFZp761D112. UniProt also describes a short isoform that cleaves fibronectin and collagen type III at a lower rate.
Mouse and rat both have an orthologous Mmp16 gene; check the datasheet of any product for its validated reactivity. UniProt links MMP16 with CSPG4-dependent type I collagen invasion by melanoma cells, and the MMP family is generally implicated in arthritis and metastasis.
Other membrane-type and secreted matrix metalloproteinases, including the gelatinase MMP2 that MMP16 activates, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P51512; product specifications from Assay Genie datasheets.